Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BENIGN PROSTATIC HYPERPLASIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1384 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reichert, W; Hartmann, RW; Jose, J
      Stable expression of the human 5 alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors

      JOURNAL OF ENZYME INHIBITION
    2. Shvartzman, P; Tandeter, H; Peleg, A; Tabenkin, H; Sasson, N; Borkan, J
      Lower urinary tract symptoms in primary care - A multicenter community-based study in Israel

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    3. Jin, Y; Penning, TM
      Steroid 5 alpha-reductases and 3 alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    4. Papatsoris, AG; Papavassiliou, AG
      Molecular 'palpation' of BPH: a tale of MAPK signalling?

      TRENDS IN MOLECULAR MEDICINE
    5. Aydos, MM; Memis, A; Yakupoglu, YK; Ozdal, OL; Oztekin, V
      The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures

      BJU INTERNATIONAL
    6. Hindley, RG; Mostafid, AH; Brierly, RD; Harrison, NW; Thomas, PJ; Fletcher, MS
      The 2-year symptomatic and urodynamic results of a prospective randomized trial of interstitial radiofrequency therapy vs transurethral resection of the prostate

      BJU INTERNATIONAL
    7. Baltaci, S; Orhan, D; Gogus, C; Turkolmez, K; Tulunay, O; Gogus, O
      Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma

      BJU INTERNATIONAL
    8. Kakizaki, H; Machino, R; Koyanagi, T
      Clinical experience in lower urinary tract symptoms

      BJU INTERNATIONAL
    9. Schwinn, DA
      The role of alpha(1)-adrenergic receptor subtypes in lower urinary tract symptoms

      BJU INTERNATIONAL
    10. Kirby, RS; Andersen, M; Gratzke, P; Dahlstrand, C; Hoye, K
      A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia

      BJU INTERNATIONAL
    11. Arnold, EP
      Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand

      BJU INTERNATIONAL
    12. Michel, MC; Neumann, HG; Mehlburger, L; Schumacher, H; Goepel, M
      Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?

      BJU INTERNATIONAL
    13. Tello, FL; Prats, CH; Gonzalez, MDD
      Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    14. Macek, J
      Separation of finasteride and analogues

      JOURNAL OF CHROMATOGRAPHY B
    15. Bowden, EA; Foley, SJ
      Haematuria; a late complication of TURP?

      PROSTATE CANCER AND PROSTATIC DISEASES
    16. Vallancien, G; Pariente, P
      Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France

      PROSTATE CANCER AND PROSTATIC DISEASES
    17. Smith, HJ; Nicholls, PJ; Simons, C; Le Lain, R
      Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

      EXPERT OPINION ON THERAPEUTIC PATENTS
    18. Azam, U; Castleden, M; Turner, D
      Economics of lower urinary tract symptoms (LUTS) in older people

      DRUGS & AGING
    19. Richard, F; Lukacs, B; Jardin, A; Lanson, Y; Chevret-Measson, M; Grange, JC; Navratil, H
      Results of an epidemiological survey of voiding disorders, quality of lifeand sexual function conducted in men aged 50 to 80 years.

      PROGRES EN UROLOGIE
    20. Parks, LG; Lambright, CS; Orlando, EF; Guillette, LJ; Ankley, GT; Gray, LE
      Masculinization of female mosquitofish in kraft mill effluent-contaminatedFenholloway River water is associated with androgen receptor agonist activity

      TOXICOLOGICAL SCIENCES
    21. Herness, EA; Naz, RK
      Prostate-specific genes: present status and future direction

      FRONTIERS IN BIOSCIENCE
    22. Guico-Pabia, CJ; Murray, JF; Teutsch, SM; Wertheimer, AI; Berger, ML
      Indirect cost of ischemic heart disease to employers

      AMERICAN JOURNAL OF MANAGED CARE
    23. McQueen, CE; Bryant, PJ
      Pygeum

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    24. Schally, AV; Gual, C
      Some recollections of early clinical studies on hypothalamic hormones: A tale of a successful international collaboration

      ENDOCRINOLOGIST
    25. Boehm, T; Malich, A; Goldberg, SN; Reichenbach, JR; Hilger, I; Fleck, M; Kaiser, WA
      Vacuum-assisted resection of malignant tumors with and without subsequent radiofrequency ablation: Feasibility of complete tumor treatment tested in an animal model

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    26. Lanzafame, RJ
      Laser use and research in gastroenterology, gynecology, and general surgery: A status report

      JOURNAL OF CLINICAL LASER MEDICINE & SURGERY
    27. Guarna, A; Occhiato, EG; Machetti, F; Trabocchi, A; Scarpi, D; Danza, G; Mancina, R; Comerci, A; Serio, M
      Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selectiveinhibitors of human 5 alpha-reductase 1

      BIOORGANIC & MEDICINAL CHEMISTRY
    28. Salinas-Sanchez, AS; Hernandez-Millan, I; Lorenzo-Romero, JG; Segura-Martin, M; Fernandez-Olano, C; Virseda-Rodriguez, JA
      Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery

      QUALITY OF LIFE RESEARCH
    29. Jakobsson, L; Loven, L; Hallberg, IR
      Sexual problems in men with prostate cancer in comparison with men with benign prostatic hyperplasia and men from the general population

      JOURNAL OF CLINICAL NURSING
    30. Reichert, W; Michel, A; Hartmann, RW; Jose, J
      Stable expression of human 5 alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identification

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    31. Tamimi, R; Mucci, LA; Spanos, E; Lagiou, A; Benetou, V; Trichopoulos, D
      Testosterone and oestradiol in relation to tobacco smoking, body mass index, energy consumption and nutrient intake among adult men

      EUROPEAN JOURNAL OF CANCER PREVENTION
    32. Hoque, A; Albanes, D; Lippman, SM; Spitz, MR; Taylor, PR; Klein, EA; Thompson, IM; Goodman, P; Stanford, JL; Crowley, JJ; Coltman, CA; Santella, RM
      Molecular epidemiologic studies within the selenium and vitamin e cancer prevention trial (SELECT)

      CANCER CAUSES & CONTROL
    33. Treagust, J; Morkane, T; Speakman, M
      Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need?

      JOURNAL OF PUBLIC HEALTH MEDICINE
    34. Fang, QK; Grover, P; Han, ZX; McConville, FX; Rossi, RF; Olsson, DJ; Kessler, DW; Wald, SA
      Practical chemical and enzymatic technologies for (S)-1,4-benzodioxan-2-carboxypiperizine intermediate in the synthesis of (S)-doxazosin mesylate

      TETRAHEDRON-ASYMMETRY
    35. Andalo, C; Bocchini, P; Pozzi, R; Galletti, GC
      Accurate mass measurement of synthetic analogues of prazosine by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    36. Murai, M; Tachibana, M; Miki, M; Shiozawa, H; Hirao, Y; Okajima, E
      Transurethral needle ablation of the prostate: An initial Japanese clinical trial

      INTERNATIONAL JOURNAL OF UROLOGY
    37. Isen, K; Sinik, Z; Alkibay, T; Sezer, C; Sozen, S; Atilla, S; Ataoglu, O; Isik, S
      Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia

      INTERNATIONAL JOURNAL OF UROLOGY
    38. Kawakami, E; Amemiya, E; Namikawa, K; Kashiwagi, C; Hori, T; Tsutsui, T
      High plasma estradiol-17 beta levels in dogs with benign prostatic hyperplasia and azoospermia

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    39. Meigs, JB; Mohr, B; Barry, MJ; Collins, MM; McKinlay, JB
      Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    40. Souverein, PC; Herings, RMC; De la Rosette, JJMCH; Man in't Veld, AJ; Farmer, RDT; Leufkens, HGM
      Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): Methodological considerations

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    41. Zitzmann, M; Nieschlag, E
      Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    42. McCabe, SJ
      Patient participation in the decision for replantation

      HAND CLINICS
    43. ter Haar, GR
      High intensity focused ultrasound for the treatment of tumors

      ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
    44. Knutson, T; Edlund, C; Fall, M; Dahlstrand, C
      BPH with coexisting overactive bladder dysfunction - An everyday urological dilemma

      NEUROUROLOGY AND URODYNAMICS
    45. Cilotti, A; Danza, G; Serio, M
      Clinical application of 5 alpha-reductase inhibitors

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    46. Keskinege, A; Elgun, S; Yilmaz, E
      Possible implications of arginase and diamine oxidase in prostatic carcinoma

      CANCER DETECTION AND PREVENTION
    47. Reek, C; Conrad, S; Heinzer, H; Huland, H
      Long-term follow-up after side-fire laser coagulation of the prostate withthe neodymium : YAG laser

      UROLOGE A
    48. Michel, MC; Bressel, HU; Goepel, M; Rubben, H
      A 6-month large-scale study into the safety of tamsulosin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    49. Dinh, DT; Frauman, AG; Casley, DJ; Johnston, CI; Fabiani, ME
      Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    50. Garcia-Losa, M; Unda, M; Badia, X; Rodriguez-Alcantara, F; Carballido, J; Dal-Re, R; Herdman, M
      Effect of mode of administration on I-PSS scores in a large BPH patient population

      EUROPEAN UROLOGY
    51. de la Rosette, JJMCH; Alivizatos, G; Madersbacher, S; Perachino, M; Thomas, D; Desgrandchamps, F; De Wildt, M
      EAU guidelines on benign prostatic hyperplasia (BPH)

      EUROPEAN UROLOGY
    52. Nuotio, M; Jylha, M; Koivisto, AM; Tammela, TLJ
      Association of smoking with urgency in older people

      EUROPEAN UROLOGY
    53. Schatzl, G; Temml, C; Waldmuller, J; Thurridl, T; Haidinger, G; Madersbacher, S
      A comparative cross-sectional study of lower urinary tract symptoms in both sexes

      EUROPEAN UROLOGY
    54. Prezioso, D; Scarpa, RM; Zattoni, F; Viaggi, S; Termini, R; Berioli, S; Rizzi, CA
      Aims and methods

      EUROPEAN UROLOGY
    55. Gentile, M; Carini, M; Morgia, G; Selvaggi, FP; Randone, D; Rosati, A
      Management of patients with LUTS suggestive of BPH

      EUROPEAN UROLOGY
    56. Prezioso, D; Catuogno, C; Galassi, P; D'Andrea, G; Castello, G; Pirritano, D
      Life-style in patients with LUTS suggestive of BPH

      EUROPEAN UROLOGY
    57. Bertaccini, A; Vassallo, F; Martino, F; Luzzi, L; Rossetti, SR; Di Silverio, F; Comunale, L
      Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH

      EUROPEAN UROLOGY
    58. Tubaro, A; Polito, M; Giambroni, L; Famulari, C; Gange, E; Ostardo, E
      Sexual function in patients with LUTS suggestive of BPH

      EUROPEAN UROLOGY
    59. Porru, D; Bartoletti, R; Austoni, E; Carrino, M; Gianneo, E; Melloni, D
      Relationship of flow rate with symptoms, quality of life and other clinical parameters in patients with LUTS suggestive of BPH

      EUROPEAN UROLOGY
    60. Hartung, R; Leyh, H; Liapi, C; Fastenmeier, K; Barba, M
      Coagulating intermittent cutting - Improved high-frequency surgery in transurethral prostatectomy

      EUROPEAN UROLOGY
    61. Berges, RR; Pientka, L; Hofner, K; Senge, T; Jonas, U
      Male lower urinary tract symptoms and related health care seeking in Germany

      EUROPEAN UROLOGY
    62. Tsai, YS; Lin, JSN; Tong, YC; Tzai, TS; Yang, WH; Chang, CC; Cheng, HL; Lin, YM; Jou, YC
      Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: Long-term durability with Prostcare

      EUROPEAN UROLOGY
    63. Yamanishi, T; Takei, K; Tobe, T; Ueda, T; Ito, H; Yasuda, K
      Transurethral holmium: YAG laser prostatectomy using a side-firing fiber for bladder outlet obstruction due to benign prostatic enlargement: Urodynamic evaluation of surgical outcome

      EUROPEAN UROLOGY
    64. Helke, C; Manseck, A; Hakenberg, OW; Wirth, MP
      Is transurethral vaporesection of the prostate better than standard transurethral resection?

      EUROPEAN UROLOGY
    65. Anderson, JB; Roehrborn, CG; Schalken, JA; Emberton, M
      The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk

      EUROPEAN UROLOGY
    66. Schelin, S
      Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention

      EUROPEAN UROLOGY
    67. Pace, G; Selvaggio, O; Palumbo, F; Selvaggi, FP
      Initial experience with a new transurethral microwave thermotherapy treatment protocol '30-minute TUMT'

      EUROPEAN UROLOGY
    68. Hakenberg, OW; Helke, C; Manseck, A; Wirth, MP
      Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia

      EUROPEAN UROLOGY
    69. Madersbacher, S; Haidinger, G; Struhal, G
      Management of lower urinary tract symptoms of eldery men in Austria

      EUROPEAN UROLOGY
    70. Hammarsten, J; Hogstedt, B
      Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

      EUROPEAN UROLOGY
    71. Xue, Y; Smedts, F; Ruijter, ET; Debruyne, FMJ; de la Rosette, JJMCH; Schalken, JA
      Branching activity in the human prostate: A closer look at the structure of small glandular buds

      EUROPEAN UROLOGY
    72. Mumtaz, FH; Dashwood, MR; Thompson, CS; Khan, MA; Naylor, AM; Mikhailidis, DP; Morgan, RJ
      Autoradiographic localisation and contractile properties of prostatic endothelin receptors in patients with bladder outlet obstruction

      EUROPEAN UROLOGY
    73. Costa, P; Perrouin-Verbe, B; Colvez, A; Didier, JP; Marquis, P; Marrel, A; Amarenco, G; Espirac, B; Leriche, A
      Quality of life in spinal cord injury patients with urinary difficulties -Development and validation of qualiveen

      EUROPEAN UROLOGY
    74. Puppo, P
      Long-term effects on BPH of medical and instrumental therapies

      EUROPEAN UROLOGY
    75. McNeill, SA
      Does acute urinary retention respond to alpha-blockers alone?

      EUROPEAN UROLOGY
    76. Hartung, R
      Do alpha-blockers prevent the occurrence of acute urinary retention?

      EUROPEAN UROLOGY
    77. Van Kerrebroeck, PEV
      The efficacy and safety of a new once-a-day formulation of an alpha-blocker

      EUROPEAN UROLOGY
    78. Chapple, CR
      Triumph: Improving the management of lower urinary tract symptoms in real life practice - Introduction and conclusions

      EUROPEAN UROLOGY
    79. Stoevelaar, HJ; McDonnell, J; Bosch, JLHR; Kahan, JP
      Lower urinary tract symptoms suggestive of benign prostatic obstruction: How can clinical expertise contribute to rational management?

      EUROPEAN UROLOGY
    80. Puppo, P
      Do we know everything about alpha-blockade in the management of lower urinary tract symptoms?

      EUROPEAN UROLOGY
    81. Yeh, CC; Hung, CF; Wang, WL; Chung, JG
      Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator human benign prostatic hyperplasia tissues

      UROLOGICAL RESEARCH
    82. Yasukawa, K; Swarz, H; Ito, Y
      Review of orthostatic tests on the safety of tamsulosin, a selective alpha(1A)-adrenergic receptor antagonist, shows lack of orthostatic hypotensive effects

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    83. Allen, JR; Prost, RW; Griffith, OW; Erickson, SJ; Erickson, BA
      In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    84. Handisurya, A; Steiner, GE; Stix, U; Ecker, RC; Pfaffeneder-Mantai, S; Langer, D; Kramer, G; Memaran-Dadgar, N; Marberger, M
      Differential expression of interleukin-15, a pro-inflammatory cytokine andT-cell growth factor, and its receptor in human prostate

      PROSTATE
    85. Doll, JA; Reiher, FK; Crawford, SE; Pins, MR; Campbell, SC; Bouck, NP
      Thrombospondin-1, vascular endothelial growth factor and fibroblast growthfactor-2 are key functional regulators of angiogenesis in the prostate

      PROSTATE
    86. Sinha, AA; Jamuar, MP; Wilson, MJ; Rozhin, J; Sloane, BF
      Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis

      PROSTATE
    87. Bretland, AJ; Reid, SV; Chapple, CR; Eaton, CL
      Role of endogenous transforming growth factor beta (TGF beta) I in prostatic stromal cells

      PROSTATE
    88. Malkowicz, SB; McKenna, WG; Vaughn, DJ; Wan, XS; Propert, KJ; Rockwell, K; Marks, SHF; Wein, AJ; Kennedy, AR
      Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia

      PROSTATE
    89. Lein, M; Jung, K; Hammerer, P; Graefen, M; Semjonow, A; Stieber, P; Ossendorf, M; Luboldt, HJ; Brux, B; Stephan, C; Schnorr, D; Loening, SA
      A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis

      PROSTATE
    90. Goepel, M; Dinh, L; Mitchell, A; Schafers, RF; Rubben, H; Michel, MC
      Do saw palmetto extracts block human alpha(1)-adrenoceptor subtypes in vivo?

      PROSTATE
    91. Demyttenaere, K; Huygens, R; Van Buggenhout, R
      Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    92. Wren, J; Karlsson, M; Loyd, D
      A hybrid equation for simulation of perfused tissue during thermal treatment

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    93. Hassler, E; Krakau, I; Haggarth, L; Norlen, L; Ekman, P
      Questioning questions about symptoms of benign prostatic hyperplasia

      FAMILY PRACTICE
    94. Liu, XL; Zhang, L; Fu, XL; Chen, K; Qian, BC
      Effect of scopoletin on PC3 cell proliferation and apoptosis

      ACTA PHARMACOLOGICA SINICA
    95. Lee, LM; Pan, CC; Cheng, CJ; Chi, CW; Liu, TY
      Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia

      ANTICANCER RESEARCH
    96. Ravindranath, N; Wion, D; Brachet, P; Djakiew, D
      Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate

      JOURNAL OF ANDROLOGY
    97. Kinniburgh, D; Anderson, RA; Baird, DT
      Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride

      JOURNAL OF ANDROLOGY
    98. Carrington, ME; Roberts, PD; Urs, NVRR; McGovern, RJ; Seijo, TE; Mullahey, JJ
      Premature fruit drop in saw palmettos caused by Colletotrichum gloeosporioides

      PLANT DISEASE
    99. Mahapokai, W; van den Ingh, TSGAM; van Mil, F; van Garderen, E; Schalken, JA; Mol, JA; van Sluijs, FJ
      Immune response in hormonally-induced prostatic hyperplasia in the dog

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    100. Chrischilles, E; Rubenstein, L; Chao, J; Kreder, KJ; Gilden, D; Shah, H
      Initiation of nonselective alpha(1)-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: A retrospective cohort study

      CLINICAL THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:36:37